Data / Form D filings / Neumentum, Inc.
Neumentum, Inc.: Form D filings
Neumentum, Inc., a pharmaceuticals company in Summit, NJ, filed 8 Form D notices with the SEC between 2017 and 2023. The latest, on April 28, 2023, reports $16.6 million sold of a $20 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 350 SPRINGFIELD AVENUE, SUITE 200, Summit, NJ, 07901
- Phone
- (908) 239-6142
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1720959
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2023 | Amendment | $20,000,000 | $16,559,757 | $3,440,243 | 33 | Sep 30, 2021 | sec.gov |
| Oct 21, 2021 | Amendment | $20,000,000 | $13,300,000 | $6,700,000 | 28 | Sep 30, 2021 | sec.gov |
| Oct 14, 2021 | New notice | $20,000,000 | $13,300,000 | $6,700,000 | 28 | Sep 30, 2021 | sec.gov |
| Nov 15, 2019 | New notice | $7,000,000 | $2,663,000 | $4,337,000 | 18 | Nov 1, 2019 | sec.gov |
| Sep 6, 2019 | Amendment | $7,000,000 | $3,020,000 | $3,980,000 | 36 | Mar 12, 2019 | sec.gov |
| Mar 27, 2019 | New notice | $7,000,000 | $1,050,000 | $5,950,000 | 9 | Mar 12, 2019 | sec.gov |
| May 25, 2018 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 38 | May 14, 2018 | sec.gov |
| Oct 31, 2017 | New notice | $6,000,000 | $5,260,000 | $740,000 | 53 | Oct 24, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Taggart McGurrin | Executive Officer | |
| Joseph Pergolizzi | Director | |
| August Moretti | Director | |
| Andrew Blank | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Apr 24, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Neumentum, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.